Carnitine palmitoyltransferase 1C promotes EMT-associated cisplatin resistance in non-small cell lung cancer cells

Objective: Lung cancer is the most common cause of cancer-related deaths worldwide. Platinum-based chemotherapy is one of the main treatment options for patients with non-small cell lung cancer (NSCLC) but the effectiveness of chemotherapy is encumbered by drug resistance. Therefore, understanding t...

Full description

Bibliographic Details

Published in:	Cancer Biology & Medicine
Main Authors:	Renjie Chen, Jiahui Wang, Shuoyu Huang, Xuefeng Hu, Xinran He, Tiange Zhang, Yunhan Hu, Huijun Wei, Sihui Nian, Yushu Huang, Zhihao Wu
Format:	Article
Language:	English
Published:	China Anti-Cancer Association 2025-01-01
Subjects:	cpt1c chemoresistance emt nedd4l nsclc
Online Access:	https://www.cancerbiomed.org/content/22/1/48